Congenic expression of tissue inhibitor of metalloproteinase in Dahl-salt sensitive hypertensive rats is associated with reduced LV hypertrophy

References

• P C Colorado, A Torre, G Kamphaus, Y Maeshima, H Hopfer, K Takahashi, R Volk, E D Zamborsky, S Herman, P K Sarkar, and et al (2000). Anti-angiogenic clues from vascular basement membrane collagen. Cancer Res 60 (9):2520–2526.
   PubMed Web of Science ®Google Scholar
• M J Cox, U A Hawkins, B D Hoit, and S C Tyagi. (2004). Attenuation of oxidative stress and remodelling by cardiac inhibitor of metalloproteinase protein transfer. Circulation 109 (17):2123–2128.
   PubMed Web of Science ®Google Scholar
• A Y Deng. (1998). Is the NOS system involved in genetic hypertension in Dahl rats?. Kidney Intern 53:1501–1511.
   PubMed Web of Science ®Google Scholar
• M R Garrett, H Dene, R Walder, Q Zhang, G T Cicila, S Assadnia, A Y Deng, and J P Rapp. (1998). Genomic scan and congenic strains for blood pressure quantitative trait loci using Dahl salt-sentive rats. Genome Res 8:711–723.
   PubMed Web of Science ®Google Scholar
• B C Henderson, N Tyagi, A Ovechkin, G K Kartha, K S Moshal, and S C Tyagi. (2007). Oxidative remodelling in pressure overload induced chronic heart failure. Euro J Heart Failure 9 (5):450–457.
   PubMed Web of Science ®Google Scholar
• M J Hunt, G M Aru, M R Hayden, C K Moore, B D Hoit, and S C Tyagi. (2002). Induction of oxidative stress and disintegrin metalloproteinase in human heart end-stage failure. Am J Physiol 283 (2):L239–L245. 2002. An editorial on this paper, L237–L238
   PubMed Web of Science ®Google Scholar
• C Julier, M Delepine, B Keavney, J Terwilliger, S Davis, D E Weeks, T Bui, X Jeunemaitre, G Velho, and P Froguel. (1997). Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10. Hum Mol Genet 6:2077–2086.
   PubMed Web of Science ®Google Scholar
• G D Kamphaus, P C Colorado, D J Panka, H Hopfer, R Ramchandran, A Torre, Y Maeshima, J W Mier, V P Sukhatme, and R Kalluri. (2000). Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 275 (2):1209–1215.
   PubMed Web of Science ®Google Scholar
• M M Lindsey, P Maxwell, and F G Dunn. (2002). TIMP-1: a marker of LV diastolic dysfunction and fibrosis in hypertension. Hypertension 40:136–141.
   PubMed Web of Science ®Google Scholar
• D Lominadze, A M Roberts, N Tyagi, K S Moshal, and S C Tyagi. (2006). Homocysteine causes cerebrovascular leakage in mice. Am J Physiol Heart & Circulatory Physiol 290:H1206–H1213.
   PubMed Web of Science ®Google Scholar
• Y Maeshima, A Sudhakar, J C Lively, K Ueki, S Kharbanda, C R Kahn, N Sonenberg, R O Hynes, and R Kalluri. (2002). Tumstatin, an endothelial cell specific inhibitor of protein synthesis. Science 295 (5552):140–143.
   PubMed Web of Science ®Google Scholar
• I Matsui, T Shimosawa, Y Uetake, H Wang, S Ogura, T Kaneko, J Liu, K Ando, and T Fujita. (2006). Protective effect of potassium agonist the hypertensive cardiac dysfunction. Hypertension 48:225–231.
   PubMed Web of Science ®Google Scholar
• V S Mujumdar, L M Smiley, and S C Tyagi. (2001). Activation of matrix metalloproteinase dilates and decreases cardiac tensile strength. Intern J Cardiol 79 (2–3):277–286.
   PubMed Web of Science ®Google Scholar
• V S Mujumdar, and S C Tyagi. (1999). Temporal Regulation of ECM Components in transition from compensatory hypertrophy to decompensatory heart failure. J Hypertension 17:261–270.
   PubMed Web of Science ®Google Scholar
• M S O'Reilly. (1997). Angiostatin: an endogenous inhibitor of angiogenesis and tumor growth. Exs 79:273–294.
   PubMedGoogle Scholar
• M S O'Reilly, T Boehm, Y Shing, N Fukai, G Vasios, W S Lane, E Flynn, J R Birkhead, B R Olsen, and J Folkman. (1997). Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88 (2):277–285.
   PubMed Web of Science ®Google Scholar
• A Palijan, R Lambert, J Dutil, Z Sivo, and A Y Deng. (2003). Comprehensive congenic coverage revealing multiple blood pressure quantitative trait loci on Dahl rat chromosome 10. Hypertension 42:515–522.
   PubMed Web of Science ®Google Scholar
• S E Pike, L Yao, K D Jones, B Cherney, E Appella, K Sakaguchi, H Nakhasi, J Teruya-Feldstein, P Wirth, G Gupta, and et al (1998). Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth. J Exp Med 188 (12):2349–2356.
   PubMed Web of Science ®Google Scholar
• R Ramchandran, M Dhanabal, R Volk, M J Waterman, M Segal, H Lu, B Knebelmann, and V P Sukhatme. (1999). Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Biochem Biophys Res Commun 255 (3):735–739.
   PubMed Web of Science ®Google Scholar
• G J Rucklidge, G Milne, B A McGaw, E Milne, and S P Robins. (1992). Turnover rates of different collagen types measured by isotope ratio mass spectrometery. Biochim Biophys Acta 11:1156–1157.
   Google Scholar
• S Shastry, and S C Tyagi. (2004). Homocysteine induces metalloproteinase and shedding of beta-1 integrin in microvessel endothelial cells. J Cell Biochem 93:207–213.
   PubMed Web of Science ®Google Scholar
• I Shiojima, K Sato, Y Izumiya, S Schiekofer, M Ito, R Liao, W S Colucci, and K Walsh. (2005). Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115 (8):2059–2064.
   PubMedGoogle Scholar
• R E Tarone. (1990). A modified Bonferroni method for discrete data. Biometrics 46:515.
   PubMed Web of Science ®Google Scholar
• S C Tyagi. (1997). Proteinases and myocardial extracellular matrix turnover. Mol Cell Biochem 168:1–12.
   PubMed Web of Science ®Google Scholar
• S C Tyagi. (2000). Physiology of extracellular matrix: Cardiovascular adapation and remodelling. Pathophys 7:177–182.
   PubMedGoogle Scholar
• S C Tyagi, and M R Hayden. (2003). Role of nitric oxide in matrix remodelling in diabetes and heart failure. Heart Failure Rev 8:23–28.
   PubMed Web of Science ®Google Scholar
• S C Tyagi, L M Smiley, and V S Mujumdar. (1999). Homocyst(e)ine impairs endocardial endothelial function. Canad J Physiol & Pharmacol 77:950–957.
   PubMed Web of Science ®Google Scholar